| node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
| ALKBH2 | SLC7A9 | ENSPPYP00000005621 | ENSPPYP00000010998 | ALKBH2 isoform 3. | Solute carrier family 7 member 9. | 0.514 |
| KIAA0513 | SLC7A9 | ENSPPYP00000008589 | ENSPPYP00000010998 | KIAA0513 isoform 1. | Solute carrier family 7 member 9. | 0.514 |
| SLC15A1 | SLC1A1 | ENSPPYP00000006228 | ENSPPYP00000021557 | Solute carrier family 15 member 1. | Amino acid transporter. | 0.642 |
| SLC15A1 | SLC1A7 | ENSPPYP00000006228 | ENSPPYP00000001556 | Solute carrier family 15 member 1. | Amino acid transporter. | 0.518 |
| SLC15A1 | SLC22A2 | ENSPPYP00000006228 | ENSPPYP00000019208 | Solute carrier family 15 member 1. | Solute carrier family 22 member 2; Mediates tubular uptake of organic compounds from circulation. Mediates the influx of agmatine, dopamine, noradrenaline (norepinephrine), serotonin, choline, famotidine, ranitidine, histamine, creatinine, amantadine, memantine, acriflavine, 4-[4- (dimethylamino)-styryl]-N-methylpyridinium ASP, amiloride, metformin, N-1-methylnicotinamide (NMN), tetraethylammonium (TEA), 1-methyl-4- phenylpyridinium (MPP), cimetidine, cisplatin and oxaliplatin. Cisplatin may develop a nephrotoxic action. Transport of creatinine is inhibited by fluoroquinolones such as [...] | 0.519 |
| SLC15A1 | SLC3A1 | ENSPPYP00000006228 | ENSPPYP00000013907 | Solute carrier family 15 member 1. | SLC3A1 isoform 1. | 0.405 |
| SLC15A1 | SLC6A19 | ENSPPYP00000006228 | ENSPPYP00000017106 | Solute carrier family 15 member 1. | Sodium-dependent neutral amino acid transporter B(0)AT1; Transporter that mediates resorption of neutral amino acids across the apical membrane of renal and intestinal epithelial cells. This uptake is sodium-dependent and chloride-independent. Requires CLTRN in kidney or ACE2 in intestine for cell surface expression and amino acid transporter activity. | 0.433 |
| SLC15A1 | SLC7A9 | ENSPPYP00000006228 | ENSPPYP00000010998 | Solute carrier family 15 member 1. | Solute carrier family 7 member 9. | 0.561 |
| SLC1A1 | SLC15A1 | ENSPPYP00000021557 | ENSPPYP00000006228 | Amino acid transporter. | Solute carrier family 15 member 1. | 0.642 |
| SLC1A1 | SLC3A1 | ENSPPYP00000021557 | ENSPPYP00000013907 | Amino acid transporter. | SLC3A1 isoform 1. | 0.705 |
| SLC1A1 | SLC3A2 | ENSPPYP00000021557 | ENSPPYP00000003628 | Amino acid transporter. | Solute carrier family 3 member 2. | 0.548 |
| SLC1A1 | SLC6A19 | ENSPPYP00000021557 | ENSPPYP00000017106 | Amino acid transporter. | Sodium-dependent neutral amino acid transporter B(0)AT1; Transporter that mediates resorption of neutral amino acids across the apical membrane of renal and intestinal epithelial cells. This uptake is sodium-dependent and chloride-independent. Requires CLTRN in kidney or ACE2 in intestine for cell surface expression and amino acid transporter activity. | 0.527 |
| SLC1A1 | SLC7A9 | ENSPPYP00000021557 | ENSPPYP00000010998 | Amino acid transporter. | Solute carrier family 7 member 9. | 0.617 |
| SLC1A7 | SLC15A1 | ENSPPYP00000001556 | ENSPPYP00000006228 | Amino acid transporter. | Solute carrier family 15 member 1. | 0.518 |
| SLC1A7 | SLC3A1 | ENSPPYP00000001556 | ENSPPYP00000013907 | Amino acid transporter. | SLC3A1 isoform 1. | 0.545 |
| SLC1A7 | SLC3A2 | ENSPPYP00000001556 | ENSPPYP00000003628 | Amino acid transporter. | Solute carrier family 3 member 2. | 0.661 |
| SLC1A7 | SLC6A19 | ENSPPYP00000001556 | ENSPPYP00000017106 | Amino acid transporter. | Sodium-dependent neutral amino acid transporter B(0)AT1; Transporter that mediates resorption of neutral amino acids across the apical membrane of renal and intestinal epithelial cells. This uptake is sodium-dependent and chloride-independent. Requires CLTRN in kidney or ACE2 in intestine for cell surface expression and amino acid transporter activity. | 0.736 |
| SLC1A7 | SLC7A9 | ENSPPYP00000001556 | ENSPPYP00000010998 | Amino acid transporter. | Solute carrier family 7 member 9. | 0.510 |
| SLC22A1 | SLC22A2 | ENSPPYP00000019207 | ENSPPYP00000019208 | Solute carrier family 22 member 1. | Solute carrier family 22 member 2; Mediates tubular uptake of organic compounds from circulation. Mediates the influx of agmatine, dopamine, noradrenaline (norepinephrine), serotonin, choline, famotidine, ranitidine, histamine, creatinine, amantadine, memantine, acriflavine, 4-[4- (dimethylamino)-styryl]-N-methylpyridinium ASP, amiloride, metformin, N-1-methylnicotinamide (NMN), tetraethylammonium (TEA), 1-methyl-4- phenylpyridinium (MPP), cimetidine, cisplatin and oxaliplatin. Cisplatin may develop a nephrotoxic action. Transport of creatinine is inhibited by fluoroquinolones such as [...] | 0.902 |
| SLC22A1 | SLC7A9 | ENSPPYP00000019207 | ENSPPYP00000010998 | Solute carrier family 22 member 1. | Solute carrier family 7 member 9. | 0.515 |
